-
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents
19 May 2025 01:42 GMT
… even IPO’ed yet,” Vilella wrote, using the abbreviation for initial public offering.
Alex … and its U.S. subsidiary Complete Genomics (GCI), with Illumina agreeing to … a jury in Delaware awarded Complete Genomics approximately $334 million after concluding …
-
StockWatch: Illumina Tumbles on Q4 Results, China Retaliation
08 Feb 2025 21:43 GMT
… ; and its U.S. subsidiary Complete Genomics, which develops genomic sequencing tools … day of trading, from the initial public offering (IPO) price of $18 to $25 … ,234 additional shares at the IPO price.
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… , MGI Tech, MGI Americas and Complete Genomics in the U.S. District … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …
-
StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback
16 Jun 2024 12:49 GMT
… its U.S. subsidiary Complete Genomics, which develops genomic sequencing … to $40.25 from the initial public offering (IPO) price of $37, as … this past week’s IPOs. That number would have … company launched its initial public offering (IPO) on February 8.